Venus Remedies Ltd Share Price

₹741.70 -27.10 (-3.52%) BSE
as updated on 18-Dec-2025 15:01 | Sector - Healthcare

Day Range

  • Day's Low:734.00
  • Day's High:760.00

  • 52 Week Low272.20
  • 52 Week High839.95

Venus Remedies Ltd's key Fundamentals

Market Cap ₹1,028 Cr.
P/E Ratio 14.6
TTM EPS 52.2
P/B Ratio 1.73
ROE 6.65
Debt to Equity 0.00
Face Value 10
BVPS 467.3
3 Year Sales Growth 2.58%

Venus Remedies Ltd's Share Price Returns

1 Day -3.52%
1 Week -6.90%
1 Month 38.40%
3 Months 78.90%
6 Months 77.80%
1 Years 136.00%
3 Years 306.00%
5 Years 468.60%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Venus Remedies Ltd Shareholding Pattern

Promoters

(41.76%)

Institutions

(2.61%)

Non-Institutions

(55.63%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Venus Remedies Ltd

Venus Remedies incorporated in 1989, is a pharmaceutical manufacturing company. The company provides formulations in area of anti-biotics and oncological therapeutics.

Company has two manufacturing facilities located in India and Germany. Company manufactures Oncological and Cefelosporine Injectable products.

Its manufacturing facility located in India has received ISO 9001, ISO, 14001 and OHSAS 18001 for quality management. Its Germany facility follows EU-GMP norms.

Presently, the company has successfully made its presence in the markets of Philippines, Thailand, Malaysia, Cambodia, Burma, Vietnam, Sri Lanka, Pakistan, Bangladesh, Nepal, Uganda, Kenya, Botswana, Zimbabwe, Sudan, Mauritius, Yemen, Iraq, Russia, Belarus, Ukraine, Costa Rica, Venezuela, Guatemala, Peru, Colombia, Ecuador, Syria, Yeman, Togo, Saudi Arbia and Iraq.

Company has entered into strategic alliances with various pharmaceutical companies to launch its R&D based specialty products. It has tie-ups with companies namely IPCA Laboratories, Elder Pharmaceuticals, Shreya Lifesciences, Cadila Healthcare, Glenmark Pharmaceuticals, Marksans Pharma, Indoco Remedies, Karle Health Sciences, Lupin and Jagsonpal Pharmaceuticals.

Company also conducts in-house research and development activities that focuses Formulation Development, NDDS (Novel Drug Delivery System), new formulations of off patented chemicals and analytical and chemical research.

Products

The company is engaged in manufacturing products catering various segments such as Oncology, Cephalosporins, Carbapenems and Other Specialties, Intravenous Products, Vials/Lyophilized Injectables, Pre-Filled Syringes, Hormones, Ampoules and Biological Products.

Milestone/ Awards

2009
Venus Remedies - Product Patent for "TOBRACEF" granted in South Africa.
Venus Bags Another Product Patent from South Africa for POTENTOX.
2010
Venus Remedies receives GMP Certification from Botswana".
Venus Remedies ties up with IMTECH and Panjab Univ to develop Typhoid detection kits.
The Company has received approval from the Reserve Bank of India for rollover of FCCB USD 5mn, with YTM @4% with maturity till February 15, 2015.
Venus Remedies research Blockbuster "Sulbactomax" gets European Union Patent"
2011
Venus Remedies Ltd wins Gold Medal for TROIS under DST - Lockheed Martin India Innovation Growth Program 2011.
Venus launches its patented research product ACHNIL” in India.
Venus Remedies wins ""India Manufacturing Excellence Award 2011.
2012
Venus Remedies introduces "Ready-to-Use"" Single Vial Taxedol in India
Venus Remedies Limited introduced TROIS that is a research based, patent protected topical nano-emulsion product in India
The Company has won Manufacturing Award for its world class manufacturing and operational excellence at the "Industry 2.0 Manufacturing Innovation Conclave 2012.
Venus wins Patent award in Silver Category.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 734.00
  • Day's High: 760.00

  • 52 Week Low272.20
  • 52 Week High839.95

Venus Remedies Ltd's key Fundamentals

Market Cap ₹1,028 Cr.
P/E Ratio 14.6
TTM EPS 52.2
P/B Ratio 1.73
ROE 6.65
Debt to Equity 0.00
Face Value 10
BVPS 467.3
3 Year Sales Growth 2.58%

Venus Remedies Ltd's Share Price Returns

1 Day -3.52%
1 Week -6.90%
1 Month 38.40%
3 Months 78.90%
6 Months 77.80%
1 Years 136.00%
3 Years 306.00%
5 Years 468.60%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×